EOSINOPHILIC ASTHMA
Clinical trials for EOSINOPHILIC ASTHMA explained in plain language.
Never miss a new study
Get alerted when new EOSINOPHILIC ASTHMA trials appear
Sign up with your email to follow new studies for EOSINOPHILIC ASTHMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Asthma drug safety check: dexpramipexole under Long-Term review
Disease control TerminatedThis study looked at the long-term safety of dexpramipexole in adults with severe eosinophilic asthma. Participants had already completed earlier phase 3 trials. The goal was to track side effects and asthma control over time. However, the study was terminated early, which may li…
Matched conditions: EOSINOPHILIC ASTHMA
Phase: PHASE3 • Sponsor: Areteia Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Asthma drug trial halted midway: what it means for patients
Disease control TerminatedThis study tested a daily pill called dexpramipexole in 654 people with severe eosinophilic asthma, a type of asthma linked to high levels of certain white blood cells. The goal was to see if the drug could reduce severe asthma attacks over a year. However, the trial was terminat…
Matched conditions: EOSINOPHILIC ASTHMA
Phase: PHASE3 • Sponsor: Areteia Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Asthma drug trial halted: Dexpramipexole's promise unfulfilled
Disease control TerminatedThis Phase 3 trial tested dexpramipexole, an oral drug, in over 1,000 people with severe eosinophilic asthma that was not well controlled by standard treatments. The goal was to see if it could reduce severe asthma attacks over a year. However, the study was terminated early, so …
Matched conditions: EOSINOPHILIC ASTHMA
Phase: PHASE3 • Sponsor: Areteia Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC